Trial Information

Summary: A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia.

Status: No longer recruiting

Protocol Number: ML19357

Sponsor: Hoffmann-La Roche

Company Division: Pharmaceutical

Official Scientific Title: A randomized, double-blind study of the effect of oral monthly Bonviva on in vivo bone micro-architecture parameters in post-menopausal women with osteopenia

Brief Summary: This 2 arm study will compare the effect of oral Bonviva (150mg, monthly) and placebo on parameters of bone micro-architecture, assessed by CT scan, bone turnover and bone mineral density. Patients will be randomized to receive either Bonviva 150mg po or placebo monthly, and measurements will be taken at baseline, and at intervals over 2 years. The anticipated time on study treatment is 2+ years, and the target sample size is 100-500 individuals. Target sample size is 150.

Study Phase: III

Study Design / Study Details:

  • Purpose: Treatment
  • Allocation: Randomized
  • Masking: Double Blind
  • Control: Placebo
  • Assignment: Parallel
  • Endpoints: Safety/Efficacy

Study Type:

Interventional

Condition: Post-Menopausal Osteopenia

Intervention Type: Drug

Intervention Name: ibandronate [Bonviva/Boniva]

Primary Outcome: 1. Trabecular BV/TV at distal radius of non-dominant arm Time frame: 12 arms

Key Secondary Outcomes: 1. Trabecular BV/TV at distal radius of non-dominant arm Time frame: 6 months and 2 years 2. Bone density, trabecular BV/TV at distal tibia Time frame: 6 months, 1 and 2 years 3. Serum CTX Time frame: Intervals throughout study 4. Lumbar hip and wrist BMD Time frame: 1 and 2 years 5. AEs and laboratory parameters Time frame: Throughout study

Inclusion Criteria:

  • post-menopausal women, aged 55-75 years;
  • diagnosed osteopenia.

Exclusion Criteria:

  • history of osteoporotic vertebral fracture;
  • contraindication to ibandronate.

Gender: Females

Age Limits: Min: 55 Years Max: 75 Years

Accepts Healthy Volunteers: No

Anticipated Start Date: January, 2007

Trial Registration Date: 07/19/2006

Date Last Updated: 08/18/2008

Link To Trial Results

Contact:

Research Site:
Located In:
Paris, France, 75018
Telephone: 973-235-5000 or 800-526-6367

 

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: September 2, 2008 at 2:14:26 PM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA